Submitted by Anonymous (not verified) on 2 October 2024 - 15:40
Orphan designation: erlotinib Treatment of patients with Olmsted syndrome, 09/12/2020 Positive
Source:
Orphan designation: erlotinib Treatment of patients with Olmsted syndrome, 09/12/2020 Positive